The economic benefit of the oral formulation of nimodipine over the intravenous formulation
- In: Hospital Pharmacy Posters
- At: Hyderabad (India) (2011)
- Type: Poster
- Poster code: HPS-P-50
- By: HADAD, Salim (Rambam Health Care Campus, Haifa, Israel)
- Co-author(s): Hadad, Salim (2. Division of Pharmacy. Rambam Health Care Campus, Haifa, Israel)
Nassar, Laila (Pharmacy service. Rambam Health Care Campus, Haifa, Israel)
Levi, Leon (Neurosurgery, Rambam Health Care Campus, Haifa, Israel)
Introduction: Nimodipine is nifedipine analogue. It differs from other Calcium channel blockers by its ability to dilate cerebral vessels to a greater extent than cardiovascular vessels. Its only FDA approved indication is subarachnoid hemorrhage, from ruptured intracranial berry aneurysm...
The drug is available as both, intravenous and oral The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019